Stocktoria

Sol-Gel Technologies Ltd. SLGL

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2018-02-01 · LEI

Sol-Gel Technologies Ltd. financials (annual)

Revenue
$174000 $129000 $22.9M $8.8M $31.3M $3.9M $1.6M $11.5M $19.4M 2016201720182019202020212022202320242025
Net income
-$20.8M -$31.6M -$32.2M -$24.6M -$29.3M $3.2M -$14.9M -$27.2M -$10.6M -$6.1M 2016201720182019202020212022202320242025
Free cash flow
-$18.9M -$26.0M -$24.5M -$23.1M -$25.7M -$7.8M -$9.7M -$17.9M -$13.9M $275000 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$19.4M$11.5M$1.6M$3.9M$31.3M$8.8M$22.9M$129,000$174,000
R&D expense$22.8M$17.8M$23.5M$12.7M$20.4M$27.9M$40.6M$28.1M$25.8M$17.0M
Operating income-$7.5M-$12.0M-$29.3M-$16.2M$3.0M-$30.2M-$25.9M-$33.5M-$31.6M-$20.8M
Income tax$0$0$0$0$0$33,000
Net income-$6.1M-$10.6M-$27.2M-$14.9M$3.2M-$29.3M-$24.6M-$32.2M-$31.6M-$20.8M
EPS (diluted)$-2.19$-3.79$-10.01$-0.65$0.14$-1.30$-1.26
Operating cash flow$322,000-$13.9M-$17.7M-$9.5M-$7.7M-$25.2M-$22.5M-$23.5M-$24.1M-$18.5M
Free cash flow$275,000-$13.9M-$17.9M-$9.7M-$7.8M-$25.7M-$23.1M-$24.5M-$26.0M-$18.9M
Cash & equivalents$11.0M$19.5M$7.5M$12.4M$20.1M$7.1M$9.4M$5.3M$5.0M$7.0M
Total assets$29.9M$35.8M$45.3M$46.6M$69.2M$59.2M$61.3M$69.7M$15.3M$11.0M
Total liabilities$7.1M$7.0M$6.6M$4.4M$13.6M$8.3M$8.8M$5.8M$68.0M$42.3M
Shareholders' equity$22.8M$28.9M$38.6M$42.2M$55.6M$50.8M$52.5M$63.9M-$52.7M-$31.3M

Growth · year-over-year · Revenue CAGR 80.2%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth+68.0%+642.5%-60.0%-87.6%+256.5%-61.7%+17655.0%-25.9%
Net income growth-563.3%
EPS growth-564.3%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.